Document
IPR2018-00943, No. 2024 Exhibit - Exhibit 2024 (P.T.A.B. Feb. 7, 2019)
Cite Document
IPR2018-00943, No. 2024 Exhibit - Exhibit 2024 (P.T.A.B. Feb. 7, 2019)
+ More Snippets
Document
IPR2018-00943, No. 2023 Exhibit - Exhibit 2023 (P.T.A.B. Feb. 7, 2019)
Cite Document
IPR2018-00943, No. 2023 Exhibit - Exhibit 2023 (P.T.A.B. Feb. 7, 2019)
+ More Snippets
Document
IPR2018-00943, No. 2037 Exhibit - Exhibit 2037 (P.T.A.B. Feb. 7, 2019)
Cite Document
IPR2018-00943, No. 2037 Exhibit - Exhibit 2037 (P.T.A.B. Feb. 7, 2019)
+ More Snippets
Document
IPR2018-00943, No. 2048 Exhibit - Exhibit 2048 (P.T.A.B. Feb. 7, 2019)
Cite Document
IPR2018-00943, No. 2048 Exhibit - Exhibit 2048 (P.T.A.B. Feb. 7, 2019)
+ More Snippets
Document
IPR2018-00943, No. 1082 Exhibit - Malcom Rowland and Thomas N Tozer, Clinical Pharmacokinetics Concepts and Applications 3rd ed 1995 (P.T.A.B. May. 7, 2019)
Cite Document
IPR2018-00943, No. 1082 Exhibit - Malcom Rowland and Thomas N Tozer, Clinical Pharmacokinetics Concepts and Applications 3rd ed 1995 (P.T.A.B. May. 7, 2019)
+ More Snippets
Document
IPR2018-00943, No. 1069 Exhibit - Bioavailability and Bioequivalence Studies for Orally Administered Drug Products General Considerations, Guidance for Industry (P.T.A.B. May. 7, 2019)
Cite Document
IPR2018-00943, No. 1069 Exhibit - Bioavailability and Bioequivalence Studies for Orally Administered Drug Products General Considerations, Guidance for Industry (P.T.A.B. May. 7, 2019)
+ More Snippets
Document
IPR2018-00943, No. 2040 Exhibit - Exhibit 2040 (P.T.A.B. Feb. 7, 2019)
Cite Document
IPR2018-00943, No. 2040 Exhibit - Exhibit 2040 (P.T.A.B. Feb. 7, 2019)
+ More Snippets
Document
IPR2018-00943, No. 2043 Exhibit - Exhibit 2043 (P.T.A.B. Feb. 7, 2019)
Cite Document
IPR2018-00943, No. 2043 Exhibit - Exhibit 2043 (P.T.A.B. Feb. 7, 2019)
+ More Snippets
Document
IPR2018-00943, No. 2025 Exhibit - Exhibit 2025 (P.T.A.B. Feb. 7, 2019)
Cite Document
IPR2018-00943, No. 2025 Exhibit - Exhibit 2025 (P.T.A.B. Feb. 7, 2019)
+ More Snippets
Document
IPR2018-00943, No. 2022 Exhibit - Exhibit 2022 (P.T.A.B. Jan. 17, 2019)
Cite Document
IPR2018-00943, No. 2022 Exhibit - Exhibit 2022 (P.T.A.B. Jan. 17, 2019)
+ More Snippets
Document
IPR2018-00943, No. 1064 Exhibit - Bertoletti et al, Effect of liver cirrhosis on the systemic availability of naltrexone in humans (P.T.A.B. May. 7, 2019)
Cite Document
IPR2018-00943, No. 1064 Exhibit - Bertoletti et al, Effect of liver cirrhosis on the systemic availability of naltrexone in humans (P.T.A.B. May. 7, 2019)
+ More Snippets
Document
IPR2018-00943, No. 1077 Exhibit - Krishna et al, Increased Intracellular Drug Accumulation and Complete Chemosensitization Achieved in Multidrug Resistant Solid Tumors by Co Administering...
Cite Document
IPR2018-00943, No. 1077 Exhibit - Krishna et al, Increased Intracellular Drug Accumulation and Complete Chemosensitization Achieved in Multidrug Resistant Solid Tumors by Co Administering Valspodar PS
+ More Snippets
Document
IPR2018-00943, No. 1089 Exhibit - Malcolm Rowland and Thomas N Tozer, Clinical Pharmacokinetics and Pharmacodynamics Concepts and Applications 4th ed2011 (P.T.A.B. May. 7, 2019)
Cite Document
IPR2018-00943, No. 1089 Exhibit - Malcolm Rowland and Thomas N Tozer, Clinical Pharmacokinetics and Pharmacodynamics Concepts and Applications 4th ed2011 (P.T.A.B. May. 7, 2019)
+ More Snippets
Document
IPR2018-00943, No. 2045 Exhibit - Exhibit 2045 (P.T.A.B. Feb. 7, 2019)
Cite Document
IPR2018-00943, No. 2045 Exhibit - Exhibit 2045 (P.T.A.B. Feb. 7, 2019)
+ More Snippets
Document
IPR2018-00943, No. 2054 Exhibit - Exhibit 2054 (P.T.A.B. Feb. 7, 2019)
Cite Document
IPR2018-00943, No. 2054 Exhibit - Exhibit 2054 (P.T.A.B. Feb. 7, 2019)
+ More Snippets